Kennedy Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
VCM
VPM
Kennedy Capital Management's BSX Position: Q1 2026 in Review
Kennedy Capital Management increased its Boston Scientific (BSX) stake by 66% in Q1 2026, buying an estimated $1.99M and bringing the position to 62,306 shares worth $3.91M. The position accounts for 0.08% of the portfolio, ranked #336.
Kennedy Capital Management first reported a position in BSX in Q2 2013 and has held it in 20 quarters since. The position peaked at $9.3M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Kennedy Capital Management held 62,306 shares of Boston Scientific worth $3.91M as of Q1 2026.
- Kennedy Capital Management bought 24,863 Boston Scientific shares in Q1 2026, an estimated $1.99M.
- Boston Scientific made up 0.08% of Kennedy Capital Management's portfolio in Q1 2026, its #336 holding.
- Kennedy Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 20 quarters since.
- Kennedy Capital Management's Boston Scientific position peaked at $9.3M in Q1 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.